Inhibition	0	10	O
of	11	13	O
Dll4	14	18	B-Gene_or_gene_product
-	18	19	O
mediated	19	27	O
signaling	28	37	O
induces	38	45	O
proliferation	46	59	O
of	60	62	O
immature	63	71	O
vessels	72	79	B-Multi-tissue_structure
and	80	83	O
results	84	91	O
in	92	94	O
poor	95	99	O
tissue	100	106	B-Tissue
perfusion	107	116	O
.	116	117	O

Vascular	119	127	B-Multi-tissue_structure
development	128	139	O
is	140	142	O
dependent	143	152	O
on	153	155	O
various	156	163	O
growth	164	170	O
factors	171	178	O
and	179	182	O
certain	183	190	O
modifiers	191	200	O
critical	201	209	O
for	210	213	O
providing	214	223	O
arterial	224	232	O
or	233	235	O
venous	236	242	O
identity	243	251	O
,	251	252	O
interaction	253	264	O
with	265	269	O
the	270	273	O
surrounding	274	285	O
stroma	286	292	B-Tissue
and	293	296	O
tissues	297	304	B-Tissue
,	304	305	O
hierarchic	306	316	B-Tissue
network	317	324	I-Tissue
formation	325	334	O
,	334	335	O
and	336	339	O
recruitment	340	351	O
of	352	354	O
pericytes	355	364	B-Cell
.	364	365	O

Notch	366	371	B-Gene_or_gene_product
receptors	372	381	O
and	382	385	O
ligands	386	393	O
(	394	395	O
Jagged	395	401	B-Gene_or_gene_product
and	402	405	O
Delta	406	411	B-Gene_or_gene_product
-	411	412	O
like	412	416	O
)	416	417	O
play	418	422	O
a	423	424	O
critical	425	433	O
role	434	438	O
in	439	441	O
this	442	446	O
process	447	454	O
in	455	457	O
addition	458	466	O
to	467	469	O
VEGF	470	474	B-Gene_or_gene_product
.	474	475	O

Dll4	476	480	B-Gene_or_gene_product
is	481	483	O
one	484	487	O
of	488	490	O
the	491	494	O
Notch	495	500	B-Gene_or_gene_product
ligands	501	508	O
that	509	513	O
regulates	514	523	O
arterial	524	532	B-Multi-tissue_structure
specification	533	546	O
and	547	550	O
maturation	551	561	O
events	562	568	O
.	568	569	O

In	570	572	O
the	573	576	O
current	577	584	O
study	585	590	O
,	590	591	O
we	592	594	O
have	595	599	O
shown	600	605	O
that	606	610	O
loss	611	615	O
of	616	618	O
function	619	627	O
by	628	630	O
either	631	637	O
targeted	638	646	O
allele	647	653	O
deletion	654	662	O
or	663	665	O
use	666	669	O
of	670	672	O
a	673	674	O
soluble	675	682	O
form	683	687	O
of	688	690	O
Dll4	691	695	B-Gene_or_gene_product
extracellular	696	709	I-Gene_or_gene_product
domain	710	716	I-Gene_or_gene_product
leads	717	722	O
to	723	725	O
inhibition	726	736	O
of	737	739	O
Notch	740	745	B-Gene_or_gene_product
signaling	746	755	O
,	755	756	O
resulting	757	766	O
in	767	769	O
increased	770	779	O
vascular	780	788	B-Multi-tissue_structure
proliferation	789	802	O
but	803	806	O
defective	807	816	O
maturation	817	827	O
.	827	828	O

Newly	829	834	O
forming	835	842	O
vessels	843	850	B-Multi-tissue_structure
have	851	855	O
thin	856	860	O
caliber	861	868	O
,	868	869	O
a	870	871	O
markedly	872	880	O
reduced	881	888	O
vessel	889	895	B-Immaterial_anatomical_entity
lumen	896	901	I-Immaterial_anatomical_entity
,	901	902	O
markedly	903	911	O
reduced	912	919	O
pericyte	920	928	B-Cell
recruitment	929	940	O
,	940	941	O
and	942	945	O
deficient	946	955	O
vascular	956	964	B-Multi-tissue_structure
perfusion	965	974	O
.	974	975	O

sDll4	976	981	B-Gene_or_gene_product
similarly	982	991	O
induced	992	999	O
defective	1000	1009	O
vascular	1010	1018	B-Multi-tissue_structure
response	1019	1027	O
in	1028	1030	O
tumor	1031	1036	B-Pathological_formation
implants	1037	1045	O
leading	1046	1053	O
to	1054	1056	O
reduced	1057	1064	O
tumor	1065	1070	B-Pathological_formation
growth	1071	1077	O
.	1077	1078	O

Interference	1079	1091	O
with	1092	1096	O
Dll4	1097	1101	B-Gene_or_gene_product
-	1101	1102	O
Notch	1102	1107	B-Gene_or_gene_product
signaling	1108	1117	O
may	1118	1121	O
be	1122	1124	O
particularly	1125	1137	O
desirable	1138	1147	O
in	1148	1150	O
tumors	1151	1157	B-Pathological_formation
that	1158	1162	O
have	1163	1167	O
highly	1168	1174	O
induced	1175	1182	O
Dll4	1183	1187	B-Gene_or_gene_product
-	1187	1188	O
Notch	1188	1193	B-Gene_or_gene_product
pathway	1194	1201	O
.	1201	1202	O

